Press release
-
Business Wire6 days ago
Akamai and Visa Collaborate to Build Trust in Agentic Commerce
Visa’s Trusted Agent Protocol to authenticate AI shopping agents and help prevent fraud across Akamai Cloud, strengthening the trust layer…
Read More » -
Business Wire6 days ago
Infinity Natural Resources Publishes Updated Hedge Positions
MORGANTOWN, W. Va.–(BUSINESS WIRE)–Infinity Natural Resources, Inc. (“Infinity” or the “Company”) (NYSE: INR) (INR) today provided an update on its…
Read More » -
Business Wire6 days ago
Gelt Launches AI-Powered Tax Calculator Hub to Quantify the Value of Advanced Tax Strategies Ahead of 2026 Tax Season
New hub delivers fast, dollar-based insights for S Corp elections, PTET, and other high-impact strategies. MIAMI–(BUSINESS WIRE)–Gelt, the AI-native tax…
Read More » -
Press Release
Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference
PITTSBURGH, Dec. 17, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will…
Read More » -
Press Release
Sealed Air Announces Expiration of “Go-Shop” Period
Transaction is Expected to Close in Mid-2026 CHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ — Sealed Air Corporation (“Sealed Air” or the…
Read More » -
Press Release
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
Partnership combines Protalix’s rare disease and biologics expertise with Secarna’s AI–powered OligoCreator® platform to jointly develop pharmaceutical candidates for rare…
Read More » -
Press Release
PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall survival when used…
Read More » -
IFS Announces IFS Unleashed and IFS Connect series dates for 2026
New Annual Pass launched IFS Unleashed confirmed for October 12-16, 2026 in Orlando, Fl IFS Connect series of 10 regional…
Read More » -
Business Wire6 days ago
KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery
First and only immunotherapy plus ADC regimen, used perioperatively, to extend survival for cisplatin-eligible patients with MIBC RAHWAY, N.J.–(BUSINESS WIRE)–Merck…
Read More » -
Press Release
Early Bitcoin Investor Nick Rose Doubles Down on Bitcoin Mining and AI Data Centers
Strategic partnerships target low-cost energy markets in developing economies LOS ANGELES, Dec. 17, 2025 /PRNewswire/ — Orion Compute, founded by early Bitcoin…
Read More »